These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36502498)

  • 41. Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).
    Bergas A; Albasanz-Puig A; Fernández-Cruz A; Machado M; Novo A; van Duin D; Garcia-Vidal C; Hakki M; Ruiz-Camps I; Del Pozo JL; Oltolini C; DeVoe C; Drgona L; Gasch O; Mikulska M; Martín-Dávila P; Peghin M; Vázquez L; Laporte-Amargós J; Durà-Miralles X; Pallarès N; González-Barca E; Álvarez-Uría A; Puerta-Alcalde P; Aguilar-Company J; Carmona-Torre F; Clerici TD; Doernberg SB; Petrikova L; Capilla S; Magnasco L; Fortún J; Castaldo N; Carratalà J; Gudiol C
    Microbiol Spectr; 2022 Jun; 10(3):e0229221. PubMed ID: 35475683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of macrolide-lincosamide resistance and multidrug resistance phenotypes in streptococcal isolates causing infections in European hospitals: Evaluation of the in vitro activity of oritavancin and comparator agents.
    Mendes RE; Castanheira M; Farrell DJ; Flamm RK; Sader HS; Jones RN
    J Glob Antimicrob Resist; 2017 Mar; 8():28-32. PubMed ID: 27939809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia.
    Brunet AS; Ploton C; Galambrun C; Pondarré C; Pages MP; Bleyzac N; Freydière AM; Barbé G; Bertrand Y
    Pediatr Blood Cancer; 2006 Nov; 47(6):765-72. PubMed ID: 16333838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High frequency of isolation of antibiotic-resistant oral Viridans streptococci from children in Kuwait.
    Rotimi VO; Salako NO; Mokaddas E; Philip L; Rajan P
    J Chemother; 2005 Oct; 17(5):493-501. PubMed ID: 16323437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital.
    Nielsen MJ; Claxton S; Pizer B; Lane S; Cooke RPD; Paulus S; Carrol ED
    Medicine (Baltimore); 2016 Mar; 95(9):e2952. PubMed ID: 26945409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of antibiotic susceptibility in viridans group streptococci in low and high antibiotic-prescribing General Practices.
    Goldsmith CE; Hara Y; Sato T; Nakajima T; Nakanishi S; Mason C; Moore JE; Matsuda M; Coulter WA
    J Clin Pharm Ther; 2015 Apr; 40(2):204-7. PubMed ID: 25604860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016).
    Pfaller MA; Flamm RK; Castanheira M; Sader HS; Mendes RE
    Int J Antimicrob Agents; 2018 Apr; 51(4):608-611. PubMed ID: 29277526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.
    Cho SY; Lee DG; Choi SM; Kwon JC; Kim SH; Choi JK; Park SH; Park YJ; Choi JH; Yoo JH
    BMC Infect Dis; 2013 Oct; 13():504. PubMed ID: 24164924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine.
    Johannsen KH; Handrup MM; Lausen B; Schrøder H; Hasle H
    Pediatr Blood Cancer; 2013 Jul; 60(7):1154-60. PubMed ID: 23281248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viridans group streptococci: an underestimated cause of spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bert F; Noussair L; Lambert-Zechovsky N; Valla D
    Eur J Gastroenterol Hepatol; 2005 Sep; 17(9):929-33. PubMed ID: 16093870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
    Uh Y; Shin DH; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
    J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Infections caused by viridans streptococci in patients with neutropenia.
    Tunkel AR; Sepkowitz KA
    Clin Infect Dis; 2002 Jun; 34(11):1524-9. PubMed ID: 12015700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A patient with penicillin-resistant viridans group streptococcal endocarditis and unusual reactions to vancomycin.
    Apiwattanakul N; Wanitkun S; Chongtrakool P; Sirinavin S
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1088-91. PubMed ID: 19062700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility.
    Husain E; Whitehead S; Castell A; Thomas EE; Speert DP
    Pediatr Infect Dis J; 2005 Jun; 24(6):563-6. PubMed ID: 15933573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16.
    Pfaller MA; Mendes RE; Duncan LR; Flamm RK; Sader HS
    J Antimicrob Chemother; 2018 Oct; 73(10):2748-2756. PubMed ID: 29982565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Viridans group streptococci in blood culture isolates in a Swedish university hospital: antibiotic susceptibility and identification of erythromycin resistance genes.
    Westling K; Julander I; Ljungman P; Jalal S; Nord CE; Wretlind B
    Int J Antimicrob Agents; 2006 Oct; 28(4):292-6. PubMed ID: 16938436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci.
    Shelburne SA; Greenberg SB; Aslam S; Tweardy DJ
    J Infect; 2007 Feb; 54(2):e99-101. PubMed ID: 16824611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ceftaroline activity tested against viridans group streptococci from US hospitals.
    Sader HS; Rhomberg PR; Castanheira M; Farrell DJ; Flamm RK; Mendes RE; Jones RN
    Diagn Microbiol Infect Dis; 2016 Mar; 84(3):232-5. PubMed ID: 26658313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015).
    Pfaller MA; Mendes RE; Sader HS; Castanheira M; Flamm RK
    J Glob Antimicrob Resist; 2017 Dec; 11():4-7. PubMed ID: 28735053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients.
    Venditti M; Baiocchi P; Santini C; Brandimarte C; Serra P; Gentile G; Girmenia C; Martino P
    Antimicrob Agents Chemother; 1989 Apr; 33(4):580-2. PubMed ID: 2729950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.